Gab2 is also important in the progression of other hematological neoplasias, such as juvenile myelomonocytic leukemia (JMML), acute myelocytic leukemia (AML), and acute lymphoblastic leukemia (ALL) [65, 69]. This evidence concerns the gene GAB2 and acute myeloid leukemia.